Skip to content

Effect of a Sugar-free Isotonic Drink on Different Health Bioparameters

Effect of a Sugar-free Isotonic Drink on Different Health Bioparameters

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06184997
Enrollment
240
Registered
2023-12-29
Start date
2024-01-08
Completion date
2024-12-31
Last updated
2025-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Brief summary

Randomized clinical trial in which 160 participants (80 men, 80 women) will be assigned to one of two groups (40 participants per group), to determine the effects of isotonic drink on different health parameters, following published recommendations. Subjects will be electronically randomized by block design into two arms: an experimental group: isotonic drink and a control group (placebo): normal water.

Interventions

OTHERINTAKE OF ISOTONIC DRINK

Intake of natural isotonic drink based on 20% Atlantic sea water, mixed with lemon and stevia.

OTHERPLACEBO

Intake of natural mineral water

Sponsors

University of Alicante
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Participants will not be aware that there are other people consuming a different type of drink than theirs. The person analyzing the results will also be unaware. However, the researchers will be aware because they need to control the supply.

Intervention model description

Participants will be assigned to group A (water, placebo) or group B (sugar-free isotonic drink), and will be instructed to consume 265 ml of water or 265 ml of sugar-free isotonic drink, respectively, every day for 12 weeks. During the study period, participants will be advised to maintain their usual diet and physical activity.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* men and women aged >18 years; * body mass index (BMI) of 18 to 25 kg/m\^2;

Exclusion criteria

* individuals who have taken medication up to 3 months before the start of the study or supplements during the study; * individuals with a history of gastrointestinal pathology or disorder such as duodenal ulcer, chronic colitis, or chronic inflammatory disease/surgery of the gastrointestinal tract (Crohn's disease, ulcerative colitis), celiac disease, or irritable bowel syndrome; * individuals with serious acute or chronic diseases, treatments, or recent surgery; * individuals with a report of serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), or gamma-glutamyl transferase (GGT) above the upper limit of the reference interval.

Design outcomes

Primary

MeasureTime frameDescription
Microbiome Indices12 weeksMicrobiome indices through stool sample; Firmicutes/Bacteroidetes, Bacteroides/Prevotella, Enterobacteria/Enterococcus, Clostridium coccoides/perfringens
Body composition12 weeksMeasurement of body composition using bioimpedance with the Biodyxpert device.
Blood pressure12 weeksMeasurement of systolic and diastolic blood pressure. Using an OMROM upper arm blood pressure monitor.
Perception of quality of life12 weeksUsing a Quality of Life Questionnaire (SF36). Quality of Life Questionnaire is a comprehensive questionnaire that covers various attributes of an individuals life. It covers a variety of demographic questions to get better quality data and information before analyzing the quality of life of an individual.The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.
Perceived stress12 weeksMeasurement of perceived stress using the Perceived Stress Scale (PSS)
BLOOD GLUCOSE12 weeksGlucose levels in blood by blood analysis.
BLOOD INSULIN12 weeksInsulin levels in blood by blood analysis.
BLOOD LIPID PORFILE12 weeksCholesterol and triglycerides levels in blood.
Specific color of urine12 weeks
Specific gravity of urine12 weeks
Minerals in urine12 weeksK+ (Potassium), Na+ (Sodium), Mg2+ (Magnesium), Ca2+ (Calcium)
Urinary pH12 weeks
Mood States Profile12 weeksThe POMS (Profile of Mood States) questionnaire is a psychological assessment tool widely used to measure mood states. It consists of a series of words or phrases that describe feelings and emotions. Participants are asked to rate each item on a scale, indicating how well it represents their mood over a specific period. The POMS measures six different mood dimensions: Tension-Anxiety, Depression-Dejection, Anger-Hostility, Vigor-Activity, Fatigue-Inertia, and Confusion-Bewilderment. It's commonly used in clinical settings, as well as in research studies, to assess the impact of various treatments or interventions on mood states. The POMS is valued for its sensitivity in detecting mood changes over time and its ability to differentiate between various mood states.
Evaluation of constipation symptoms by the patient12 weeksThe PAC-SYM (Patient Assessment of Constipation Symptoms) is a self-report questionnaire designed to evaluate the symptoms of constipation from the patient's perspective. It is commonly used in clinical research and practice to assess the severity and impact of constipation symptoms. The questionnaire includes a series of items that ask patients to rate the frequency and severity of their constipation-related symptoms, such as abdominal discomfort, straining, and incomplete bowel movements.
Evaluation of the quality of life of patients with constipation (PAC-QOL)12 weeksThe PAC-QOL (Patient Assessment of Constipation Quality of Life) questionnaire is a specialized tool designed to assess the quality of life in individuals suffering from constipation. It is a patient-reported outcome measure that focuses on how constipation affects a person's daily life, well-being, and overall health.
Sleep quality12 weeksMeasurement of sleep quality using the Pittsburgh sleep quality index.
Liver biomarkers12 weeksMeasurement of liver biomarkers through a blood test; Aspartate aminotransferase (AST or GOT), Alanine aminotransferase (ALT or GPT) and Bilirubin

Secondary

MeasureTime frameDescription
Weight12 weeksWeight evaluation using a digital scale

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026